NEW YORK (Reuters Health) – Rectal diclofenac, oral ibuprofen, and oral acetaminophen are ineffective for preventing recurrences of febrile seizures in children, new research suggests. Moreover, such agents…
NEW YORK (Reuters Health) – Imipenem-resistant Pseudomonas aeruginosa (IRPA) is an emerging problem and, in the ICU, patient-to-patient transmission may occur, even in the absence of an outbreak,…
NEW YORK (Reuters Health) – Doubling the standard dose of fluvestrant improves the efficacy of the drug against breast cancer without affecting tolerability, new research suggests. Moroever, at…
NEW YORK (Reuters Health) – Treatment with fluvastatin both before and after vascular surgery decreases the incidence of cardiovascular death and myocardial infarction, according to results of a…
NEW YORK (Reuters Health) – New research suggests that fluoroquinolones may cause diplopia in some patients. “According to World Health Organization criteria, the relationship between fluoroquinolone therapy and…
NEW YORK (Reuters Health) – Adding dual antiplatelet therapy on top of existing anticoagulant therapy increases the bleeding risk after percutaneous coronary stenting, according to results from the…
NEW YORK (Reuters Health) – A long-term trial has shown “no evidence to support the use of endovascular treatment” for carotid artery stenosis over endarterectomy in patients who…
NEW YORK (Reuters Health) – Higher diastolic blood pressure is independently associated with impaired cognitive function in otherwise healthy middle-aged and older adults, new research suggests. Findings from…
NEW YORK (Reuters Health) – Nadroparin, a low-molecular-weight heparin, reduces the incidence of thromboembolic events in ambulatory patients receiving chemotherapy for metastatic or locally advanced solid cancers, an…
NEW YORK (Reuters Health) – In patients with acute coronary syndromes (ACS), ticagrelor appears to be more effective than clopidogrel in reducing the incidence of death from vascular…